The ‘Top 5’ List of Overused Cancer Tests and ... - CLL Support

CLL Support

23,088 members39,649 posts

The ‘Top 5’ List of Overused Cancer Tests and Treatments according to ASCO

AussieNeil profile image
AussieNeilPartnerAdministrator
2 Replies

In late October, the American Society of Clinical Oncology (ASCO) issued a “Top 5” list of tests and treatments that are routinely used by oncologists despite a lack of evidence that they are cost effective or beneficial to patients.

Three are particularly relevant to SLL/CLL patients undergoing treatment:

1. Do not give anti-nausea drugs (anti-emetics) to patients starting on chemotherapy regimens that have a low or moderate risk of causing nausea and vomiting.

3. Avoid using advanced imaging technologies (PET, CT, and radionuclide bone scans) to monitor for a cancer recurrence in patients who have finished initial treatment and have no signs or symptoms of cancer.

5. Do not use a targeted therapy intended for use against a specific genetic abnormality unless a patient’s tumor cells have a specific biomarker that predicts a favorable response to the targeted therapy.

Full article:

cancernetwork.com/news/asco...

Personally I have no issue with these sensible suggestions, but I do have some comments.

1. Controlling any nausea resulting from chemotherapy treatment can make a huge difference to how well you get through the treatment, so make sure you keep a diary of your nausea so you do get anti-emetics if you ned them:

healthunlocked.com/cllsuppo...

3. When it comes to the right amount and right type of imaging, you do really need to be in the care of a specialist experienced in CLL treatment.

5. I wish! We know that some standard CLL treatments just don't work well for some relatively common genetic abnormalities in CLL cells, yet those tests are not available in many countries and only available via specialist centres in the USA.

Neil

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .
Read more about...
2 Replies
PaulaS profile image
PaulaSVolunteer

Thanks for this, Neil. Interesting. But I was very concerned at the recommendation NOT to give anti-nausea drugs if there was only a low/moderate risk of nausea from a particular treatment. However, the small print in the article (which they don't make clear in their summing up), seems to say that it is just the more expensive anti-emetics which are not recommended, because "patients at lower risk for nausea and vomiting typically do just as well with older, less costly drugs".

So, they're not actually saying "don't give any anti-nausea drugs", but just "use the cheaper ones". That was a bit reassuring but not entirely so. And to anyone just reading the summarised list of "Top 5" overused tests etc, the distinction between cheap and expensive anti-emetics is not made clear. I'd be interested to know which are the cheaper and which more expensive ones, and which are most commonly used in CLL treatments.

Paula

Cllcanada profile image
CllcanadaTop Poster CURE Hero

I had 3 anti-nausea meds during treatment, Ondansetron, Prochorperazine and Dimenhydrinate.

The trick to using these I found is to use them BEFORE you need then, keep ahead of the nausea.

The chemoimmunotherapy treatment nausea was extremely mild, however, radiotherapy caused extreme nausea for 10 days... :-(

Like everything in CLL it varies from patient to patient.

Not what you're looking for?

You may also like...

An exercise pill would be prescribed to every cancer patient worldwide and viewed as a major breakthrough in cancer treatment

Today, Australia’s peak body representing health professionals who treat people with cancer, has...

Exercise is the best medicine after surgery or cancer treatment. Introducing a new field of study "Exercise Oncology Research".

The exercise clinic is actually co-located with the chemotherapy or radiation therapy wards at...

YABTKi or Yet Another BTK inhibitor - the A to Z list of Bruton's Tyrosine Kinase Inhibitors for CLL following Ibrutinib's success

I'll admit that YABTKi is not a recognised CLL related acronym, (acronym lists are here...

Chronic lymphocytic leukemia treatment algorithm 2022

This 29 November 2022 review article published in the Blood Cancer Journal presents an...

Relative risk for secondary bone marrow cancer within 5 years after initial CLL chemoimmunotherapy treatment (typically BR or FCR)

In countries where targeted therapies ('brutinibs, venetoclax, obinutuzumab/rituximab) are now...